α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 20 setembro 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis

Role of Anti-Beta-1-Adrenergic Receptor Antibodies in Cardiac Dysfunction in Patients with Cirrhotic Cardiomyopathy

Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

The Cardiac β-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease

Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia - ScienceDirect

Frontiers Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis

Arrhythmogenic Remodeling of β2 Versus β1 Adrenergic Signaling in the Human Failing Heart

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Targeting of G-protein coupled receptors in sepsis - ScienceDirect

Pharmacogenetics of the human beta-adrenergic receptors

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Crystal structure of the α1B-adrenergic receptor reveals molecular determinants of selective ligand recognition

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Labetalol - an overview

Recomendado para você